Cellworks Group Inc
PrivateLast Round
Strategic
Jan 9, 2023
Total Funding Raised
$33.5M
Company Overview
Cellworks Group Inc is a biotechnology company that provides a biosimulation platform designed to predict therapy response for individual patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellworks Group Inc Comparables
Compare Cellworks Group Inc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nova In Silico | 84% | |
| QuantHealth | 84% | |
| VeriSIM Life | 81% |
Cellworks Group Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 9, 2023 | ||||
| Series B | Dec 26, 2012 | ||||
| Series B | Oct 1, 2012 | ||||
| Series A | May 11, 2012 |
Cellworks Group Inc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agilent Ventures | Series B, Series A, Strategic |
| Sequoia Capital | Series A, Series B, Strategic |
| Bering Capital | Series B, Series A |
| Artiman | Series B, Series A |
Cellworks Group Inc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cellworks Group Inc's valuation, stock price, and market status.
Is Cellworks a public or private company?
Cellworks is a private company.
What is the current stock price of Cellworks?
Cellworks is a private company with no public stock price. No recent secondary market data is available.
How much is Cellworks worth (valuation)?
Valuation information for Cellworks is not publicly available.
Can I buy Cellworks stock?
Cellworks shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cellworks's last funding round?
Cellworks's most recent funding round was Strategic on January 9, 2023.
Who are the main investors in Cellworks?
Key investors in Cellworks include Agilent Ventures, Sequoia Capital, UnitedHealth Group.
Will Cellworks IPO soon?
No public IPO plans have been announced for Cellworks.
How can I track Cellworks secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellworks's secondary market activity and sign up for updates.